MetLife Investment Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Buy |
|
|||||
|
2025
Q1 | $136K | Buy |
|
|||||
|
2024
Q4 | $124K | Sell |
|
|||||
|
2024
Q3 | $151K | Hold |
|
|||||
|
2024
Q2 | $150K | Buy |
|
|||||
|
2024
Q1 | $152K | Sell |
|
|||||
|
2023
Q4 | $144K | Hold |
|
|||||
|
2023
Q3 | $142K | Hold |
|
|||||
|
2023
Q2 | $177K | Hold |
|
|||||
|
2023
Q1 | $158K | Hold |
|
|||||
|
2022
Q4 | $227K | Hold |
|
|||||
|
2022
Q3 | $269K | Buy |
|
|||||
|
2022
Q2 | $277K | Hold |
|
|||||
|
2022
Q1 | $282K | Buy |
|
|||||
|
2021
Q4 | $220K | Hold |
|
|||||
|
2021
Q3 | $864K | Hold |
|
|||||
|
2021
Q2 | $529K | Buy |
|
|||||
|
2021
Q1 | $343K | Sell |
|
|||||
|
2020
Q4 | $290K | Buy |
|